Prof. Dr. Patrick Most Email & Phone Number
Who is Prof. Dr. Patrick Most? Overview
A concise factual answer block for searchers comparing this professional profile.
Prof. Dr. Patrick Most is listed as Professor Abteilungsleiter at University of Heidelberg, a with 1183 employees, based in Frankfurt Rhine-Main Metropolitan Area, Germany. AeroLeads shows a matched LinkedIn profile for Prof. Dr. Patrick Most.
Prof. Dr. Patrick Most previously worked as Gründer und CEO biomedizinisches Start-up AaviGen GmbH at Aavigen Gmbh - Personalized, Precise, Simple, Safe and Managing Director uniQure Germany GmbH at Uniqure. Prof. Dr. Patrick Most holds Dr. Med., Medicine from Ruprecht-Karls-Universität Heidelberg.
Email format at University of Heidelberg
This section adds company-level context without repeating Prof. Dr. Patrick Most's masked contact details.
Review company-level records connected to Prof. Dr. Patrick Most before choosing the right outreach path.
About Prof. Dr. Patrick Most
Research into the molecular causes and mechanisms of disease has a high potential for innovation and value creation. We are breaking new ground in order to make the findings of basic medical research and clinical care available for the recovery of our patients and the benefit of our society. This allows us to develop therapeutic and diagnostic concepts with high efficiency and quality to the biotechnological prototype stage, which marks the professional interface at the transition from academic to post-academic space. Our inaugural success in establishing and exiting a biotech start-up, InoCard GmbH, in 2014 and 2017, respectively, exemplifies this commitment. The expertise garnered through these endeavors serves as a solid foundation for future professionally designed ventures, such as AaviGen GmbH (https://aavigen.com), which consistently advances the therapeutic and diagnostic concepts of InoCard. Our mission is to provide personalized precision medicine for cardiovascular and cardiopulmonary diseases. We achieve this by combining the strengths of the academic and bioindustrial (post-academic) sectors and challenging traditional thought patterns. A current focus is on the use of nucleic acid- and peptide-based therapeutics, which can be targeted to the heart muscle by organ-specific adeno-associated viruses (AAV), among other things.Drawing from our experience as founders of InoCard and AaviGen in an academic environment, the development and management of uniQure Germany in Heidelberg as a model project, and as uniQure leadership team member in an international environment, we bring a unique blend of medical and scientific expertise, coupled with the economic acumen and experience of the biotech industry.With the previous financing rounds for AaviGen (https://aavigen.com), the strategic partnerships and our SAB, we have laid a solid foundation for the clinical transition of the next generation of precision gene therapies for genetic and acquired forms of heart failure. If you are interested, please visit our AaviGen linkedin account to find out about the latest developments as our start-up enters the next stage of growth.
Listed skills include Research, Cardiology, Gentherapie, Translationale Medizin, and 11 others.
Prof. Dr. Patrick Most's current company
Company context helps verify the profile and gives searchers a useful next step.
Prof. Dr. Patrick Most work experience
A career timeline built from the work history available for this profile.
Professor Abteilungsleiter
Current- Chair, Molecular and Translational Cardiology Division, Heidelberg University Hospital, University of Heidelberg (June 2010)- Translational academic research facility/ pipeline for molecular therapy and theranostic development; USP: biotechnological/-pharmaceutical compatability- Inventor of the S100A1 technology for cardiac, vascular and pulmonary diseases- Co-founder of InoCard GmbH (aquired by uniQure NV; licensed to Bristol-Myers Squibb)- Co-founder of AaviGen GmbH -… Show more - Chair, Molecular and Translational Cardiology Division, Heidelberg University Hospital, University of Heidelberg (June 2010)- Translational academic research facility/ pipeline for molecular therapy and theranostic development; USP: biotechnological/-pharmaceutical compatability- Inventor of the S100A1 technology for cardiac, vascular and pulmonary diseases- Co-founder of InoCard GmbH (aquired by uniQure NV; licensed to Bristol-Myers Squibb)- Co-founder of AaviGen GmbH - Personalized, Precise, Simple, Safe Show less
Gründer Und Ceo Biomedizinisches Start-Up Aavigen Gmbh
CurrentGründer der AaviGen GmbH. Die AaviGen (https://aavigen.com) setzt auf dem Erfolg der InoCard GmbH auf und verfolgt das Ziel der Entwicklung und Kommerzialisierung personalisierter rAAV-basierter Gentherapien kardiovaskulärer und kardiopulmonaler Erkrankungen mit der ersten Leitindikation Herzmuskelschwäche.
Managing Director Uniqure Germany Gmbh
- Founder of InoCard GmbH (Dec. 2013); aquired by uniQure NV (July 2014), licensed to Bristol-Myers Squibb (April 2015)- Inventor of patented S100A1 technologies (Nucleic acid and peptides) against cardiac diseases- Managing Director of uniQure GmbH Germany (Cardiac/heart failure gene therapy program) with the purpose to lead pre-clinical and clinical AAV-S100A1 heart failure therapy development
Gründer Und Ceo Biomedizinisches Start-Up Inocard Gmbh
Gründer und CEO der InoCard GmbH mit erfolgreichem Exit 2014/2017. Die InoCard GmbH verfolgte das Ziel der Entwicklung einer rAAV9-basierten S100A1 Gentherapie der chronischen Herzmuskelschwäche. Das InoCard S100A1 Gentherapieprogramm wurde unmittelbar nach ihrer Gründung durch die niederländische Gentherapiefirma uniQure vollständig akquiriert und Grundlage einer umfassenden und andauernden Entwicklungspartnerschaft mit Bristol-Myers Squibb.
Associate Professor Of Medicine
- Faculty appointment in Sept. 2006 in the Division of Cardiology, Department of Medicine- PI within the Center for Translational Medicine; Laboratory for cardiac stem cell & gene therapy
Colleagues at University of Heidelberg
Other employees you can reach at uni-heidelberg.de. View company contacts for 1183 employees →
Umer Mahmood
Colleague at University Of HeidelbergFrankfurt Rhine-Main Metropolitan Area, Germany
View →
NE
Nicole Echner
Colleague at University Of HeidelbergFrankfurt Rhine-Main Metropolitan Area, Germany
View →
AM
Alexander Maßmann
Colleague at University Of HeidelbergFrankfurt Rhine-Main Metropolitan Area, Germany
View →
VM
Valeira Mlaieva
Colleague at University Of HeidelbergFrankfurt Rhine-Main Metropolitan Area, Germany
View →
IP
Inken Prohl
Colleague at University Of HeidelbergFrankfurt Rhine-Main Metropolitan Area, Germany
View →
IK
Ivan Kuzmanov
Colleague at University Of HeidelbergGermany
View →
NW
Norbert Weidner
Colleague at University Of HeidelbergFrankfurt Rhine-Main Metropolitan Area, Germany
View →
PD
Prof. Dr. Sonja Thaler
Colleague at University Of HeidelbergMannheim, Baden-Württemberg, Germany
View →
BT
Bettina Thiele Op Heidelberg
Colleague at University Of HeidelbergHeidelberg, Baden-Württemberg, Germany
View →
VG
Velmurugan Gunasekaran
Colleague at University Of HeidelbergHeidelberg, Baden-Württemberg, Germany
View →
Prof. Dr. Patrick Most education
Dr. Med., Medicine
Education record
Frequently asked questions about Prof. Dr. Patrick Most
Quick answers generated from the profile data available on this page.
What company does Prof. Dr. Patrick Most work for?
Prof. Dr. Patrick Most works for University of Heidelberg.
What is Prof. Dr. Patrick Most's role at University of Heidelberg?
Prof. Dr. Patrick Most is listed as Professor Abteilungsleiter at University of Heidelberg.
Where is Prof. Dr. Patrick Most based?
Prof. Dr. Patrick Most is based in Frankfurt Rhine-Main Metropolitan Area, Germany while working with University of Heidelberg.
What companies has Prof. Dr. Patrick Most worked for?
Prof. Dr. Patrick Most has worked for University Of Heidelberg, Aavigen Gmbh - Personalized, Precise, Simple, Safe, Uniqure, Inocard Gmbh, and Thomas Jefferson University.
Who are Prof. Dr. Patrick Most's colleagues at University of Heidelberg?
Prof. Dr. Patrick Most's colleagues at University of Heidelberg include Umer Mahmood, Nicole Echner, Alexander Maßmann, Valeira Mlaieva, and Inken Prohl.
How can I contact Prof. Dr. Patrick Most?
You can use AeroLeads to view verified contact signals for Prof. Dr. Patrick Most at University of Heidelberg, including work email, phone, and LinkedIn data when available.
What schools did Prof. Dr. Patrick Most attend?
Prof. Dr. Patrick Most holds Dr. Med., Medicine from Ruprecht-Karls-Universität Heidelberg.
What skills is Prof. Dr. Patrick Most known for?
Prof. Dr. Patrick Most is listed with skills including Research, Cardiology, Gentherapie, Translationale Medizin, Molecular Biology, Biowissenschaften, Molekularbiologie, and Medizin.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial